---
$id: https://graph.org.ai/products/commodity/51361909
$type: Product
source: UNSPSC
code: "51361909"
title: "Butalbital"
class: "51361900"
classTitle: "Hypnotic barbiturates"
family: "51360000"
familyTitle: "Hypnotics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Butalbital

**UNSPSC Code**: 51361909
**Class**: [Hypnotic barbiturates](Hypnotic barbiturates.mdx)
**Family**: [Hypnotics](../Hypnotics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a barbiturate with the molecular formula C11H16N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KHS0AZ4JVK, chemically known as 2,4,6(1h,3h,5h)-pyrimidinetrione, 5-(2-methylpropyl)-5-(2-propenyl)- but generally known as butalbital, which bears US NIH Compound Identifier 2481. Butalbital most often comes in base and sodium forms. European Medicines Agency schedules Butalbital in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05999MIG. The term BUTALBITAL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 23, No. 10 1969, List 9). BUTALBITAL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule butalbital under HS 29335390 and SITC 51576. As of Q4 2014, BUTALBITAL remains the US FDA Preferred Term for this commodity. Butalbital bears US NLM identifiers UMLS ID C0054234 and NCI Concept Code C47425. SMILES: CC(C)CC1(C(=O)NC(=O)NC1=O)CC=C.

